Article

Osimertinib-related Pulmonary Fibrosis, A case report and review of literature

2024-01-18

Abstract excerpt

Lung cancers are the leading cause of mortality worldwide. Pulmonary malignancies are grossly divided into small-cell lung carcinoma and non-small-cell lung carcinoma. Non-small cell lung carcinoma contributes to the majority of tumor burden. The treatment regimen and subsequent prognosis for lung cancer depend on the type of cancer, the grade, and the stage. With the advancement in modern immunology and genetics,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7f4852d2-fc3d-5a22-8695-15fe415f82dd
DOI: 10.21203/rs.3.rs-3868217/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Osimertinib-related Pulmonary Fibrosis, A case report and review of literatureDOI 10.21203/rs.3.rs-3868217/v1Read

Efficacy of Osimertinib in Lung Squamous Cell Carcinoma Patients with EGFR Gene Mutation-Case Report and a Literature Review.Semantic proximity Read

Safety of EGFR-TKIs for EGFR mutation-positive non-small cell lung cancer.Semantic proximity Read

Real-world use of osimertinib for epidermal growth factor receptor T790M-positive non-small cell lung cancer in Japan.Semantic proximity Read

A review of Osimertinib in NSCLC and pharmacist role in NSCLC patient care.Semantic proximity Read

Recent Insights into Osimertinib Analogues against EGFR Positive Non-small Cell Lung Cancer.Semantic proximity Read

A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study.Semantic proximity Read

Life-threatening pneumonitis after first-line treatment with osimertinib for primary T790M mutated non-small cell lung cancer.Semantic proximity Read

First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002).Semantic proximity Read

Molecular and Clinical Features of EGFR-TKI-Associated Lung Injury.Semantic proximity Read

The efficacy and safety of osimertinib in treating nonsmall cell lung cancer: A PRISMA-compliant systematic review and meta-analysis.Semantic proximity Read

Osimertinib-Associated Toxic Epidermal Necrolysis in a Lung Cancer Patient Harboring an EGFR Mutation-A Case Report and a Review of the Literature.Semantic proximity Read

[Pulmonary manifestations induced by osimertinib].Semantic proximity Read